Literature DB >> 2456993

Monoclonal antibody mapping of keratins 8 and 17 and of vimentin in normal human mammary gland, benign tumors, dysplasias and breast cancer.

V I Guelstein1, T A Tchypysheva, V D Ermilova, L V Litvinova, S M Troyanovsky, G A Bannikov.   

Abstract

The distribution of keratins 8 and 17 and of vimentin in 28 normal human mammary tissue samples, 16 benign tumors, 26 fibrocytic diseases and 52 malignant breast tumors have been studied using monoclonal antibodies HI, E3 and NT30, respectively. Three cell populations in normal mammary epithelium have been identified: luminal epithelium containing keratin 8, myoepithelium of the lobular structures positive for vimentin, and myoepithelium of extralobular ducts positive for keratin 17. In different kinds of benign tumor and dysplastic proliferation a mosaic of cells with all normal phenotypes has been observed. The majority of cells co-expressed keratins 8 and 17 or vimentin. In the overwhelming majority of carcinomas, cells did not contain myoepithelial markers (keratin 17 and vimentin) but expressed only keratin 8 specific to normal luminal epithelium.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2456993     DOI: 10.1002/ijc.2910420202

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  44 in total

Review 1.  Tissue architecture and breast cancer: the role of extracellular matrix and steroid hormones.

Authors:  R K Hansen; M J Bissell
Journal:  Endocr Relat Cancer       Date:  2000-06       Impact factor: 5.678

2.  Changes in cytokeratin expression accompany squamous metaplasia of the human respiratory epithelium.

Authors:  P Stosiek; M Kasper; R Moll
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1992

3.  Down-regulation of a calmodulin-related gene during transformation of human mammary epithelial cells.

Authors:  P Yaswen; A Smoll; D M Peehl; D K Trask; R Sager; M R Stampfer
Journal:  Proc Natl Acad Sci U S A       Date:  1990-10       Impact factor: 11.205

4.  Differential immunohistochemical detection of cytokeratins and vimentin in the surgically removed human endolymphatic duct and sac.

Authors:  L J Bauwens; J C De Groot; F C Ramaekers; F Linthicum; J E Veldman; E H Huizing
Journal:  Eur Arch Otorhinolaryngol       Date:  1991       Impact factor: 2.503

5.  Myoepithelial molecular markers in human breast carcinoma PMC42-LA cells are induced by extracellular matrix and stromal cells.

Authors:  Stephanie C Lebret; Donald F Newgreen; Mark C Waltham; John T Price; Erik W Thompson; M Leigh Ackland
Journal:  In Vitro Cell Dev Biol Anim       Date:  2006 Nov-Dec       Impact factor: 2.416

6.  Activated keratinocytes in the epidermis of hypertrophic scars.

Authors:  M Machesney; N Tidman; A Waseem; L Kirby; I Leigh
Journal:  Am J Pathol       Date:  1998-05       Impact factor: 4.307

7.  Cytokeratin intermediate filament expression in benign and malignant breast disease.

Authors:  M Heatley; P Maxwell; C Whiteside; P Toner
Journal:  J Clin Pathol       Date:  1995-01       Impact factor: 3.411

8.  Cytokeratin profile of immunomagnetically separated epithelial subsets of the human mammary gland.

Authors:  S Dairkee; H W Heid
Journal:  In Vitro Cell Dev Biol Anim       Date:  1993-05       Impact factor: 2.416

9.  Novel model for basaloid triple-negative breast cancer: behavior in vivo and response to therapy.

Authors:  Lisa D Volk-Draper; Sandeep Rajput; Kelly L Hall; Andrew Wilber; Sophia Ran
Journal:  Neoplasia       Date:  2012-10       Impact factor: 5.715

10.  Evidence that transgenes encoding components of the Wnt signaling pathway preferentially induce mammary cancers from progenitor cells.

Authors:  Yi Li; Bryan Welm; Katrina Podsypanina; Shixia Huang; Mario Chamorro; Xiaomei Zhang; Tracey Rowlands; Mikala Egeblad; Pam Cowin; Zena Werb; Lee K Tan; Jeffrey M Rosen; Harold E Varmus
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-10       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.